Urbinati D - Search Results

1

COVID-19 impact on the decision process of the Italian Medicine Agency: a quantitative assessment.

Canali B, Candelora L, Fiorentino F, Halmos T, La Malfa P, Massara F, Vassallo C, Urbinati D. Canali B, et al. Among authors: urbinati d. Glob Reg Health Technol Assess. 2023 May 31;10:46-52. doi: 10.33393/grhta.2023.2560. eCollection 2023 Jan-Dec. Glob Reg Health Technol Assess. 2023. PMID: 37275270 Free PMC article.

2

Cost-effectiveness analysis of Vaborem in Carbapenem-resistant Enterobacterales (CRE) -Klebsiella pneumoniae infections in Italy.

Mennini FS, Gori M, Vlachaki I, Fiorentino F, Malfa P, Urbinati D, Andreoni M. Mennini FS, et al. Among authors: urbinati d. Health Econ Rev. 2021 Oct 30;11(1):42. doi: 10.1186/s13561-021-00341-z. Health Econ Rev. 2021. PMID: 34716794 Free PMC article.

3

An Italian individual-level data study investigating on the association between air pollution exposure and Covid-19 severity in primary-care setting.

Pegoraro V, Heiman F, Levante A, Urbinati D, Peduto I. Pegoraro V, et al. Among authors: urbinati d. BMC Public Health. 2021 May 12;21(1):902. doi: 10.1186/s12889-021-10949-9. BMC Public Health. 2021. PMID: 33980180 Free PMC article.

4

Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children.

Pegoraro V, Urbinati D, Visser GHA, Di Renzo GC, Zipursky A, Stotler BA, Spitalnik SL. Pegoraro V, et al. Among authors: urbinati d. PLoS One. 2020 Jul 20;15(7):e0235807. doi: 10.1371/journal.pone.0235807. eCollection 2020. PLoS One. 2020. PMID: 32687543 Free PMC article.

5

Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database.

Marzioni M, Bassanelli C, Ripellino C, Urbinati D, Alvaro D. Marzioni M, et al. Among authors: urbinati d. Dig Liver Dis. 2019 May;51(5):724-729. doi: 10.1016/j.dld.2018.11.008. Epub 2018 Nov 17. Dig Liver Dis. 2019. PMID: 30584000 Free article.

6

Overview of external reference pricing systems in Europe.

Rémuzat C, Urbinati D, Mzoughi O, El Hammi E, Belgaied W, Toumi M. Rémuzat C, et al. Among authors: urbinati d. J Mark Access Health Policy. 2015 Sep 10;3. doi: 10.3402/jmahp.v3.27675. eCollection 2015. J Mark Access Health Policy. 2015. PMID: 27123181 Free PMC article.

7

HTA Approach in Italy. Structure, Methods, And Process Of Veneto Region's Evaluation Of Pharmaceutical Effectiveness Unit (Unità Di Valutazione Dell'efficacia Del Farmaco, Uvef).

Young KE, Urbinati D, Toumi M. Young KE, et al. Among authors: urbinati d. Value Health. 2014 Nov;17(7):A442-3. doi: 10.1016/j.jval.2014.08.1166. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201191 Free article. No abstract available.

8

Funding Integrated Health Care Services.

Belgaied W, Urbinati D, Toumi M. Belgaied W, et al. Among authors: urbinati d. Value Health. 2014 Nov;17(7):A422. doi: 10.1016/j.jval.2014.08.1044. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201073 Free article. No abstract available.

9

An Overview of the Biosimilar Market in the Us.

Young KE, Rémuzat C, Urbinati D, Toumi M. Young KE, et al. Among authors: urbinati d. Value Health. 2014 Nov;17(7):A410. doi: 10.1016/j.jval.2014.08.968. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201005 Free article. No abstract available.

10

Boosting Biosimilars Uptake in European Countries.

Young KE, Rémuzat C, Urbinati D, Toumi M. Young KE, et al. Among authors: urbinati d. Value Health. 2014 Nov;17(7):A408-9. doi: 10.1016/j.jval.2014.08.958. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200994 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page